Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,531
Total Claims
$688K
Drug Cost
357
Beneficiaries
$1,926
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-71%
Opioid rate vs peers
0.6% vs 2.2% avg
+36%
Cost per patient vs peers
$1,926 vs $1,411 avg
+26%
Brand preference vs peers
13.4% vs 10.6% avg
Opioid Prescribing
0.6%
Opioid Rate
68
Opioid Claims
$1,086
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,405 claims · $520K
Generic: 9,105 claims · $166K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 287 | $131K |
| Rifaximin | 14 | $62K |
| Dulaglutide | 63 | $41K |
| Insulin Glargine,hum.Rec.Anlog | 129 | $27K |
| Empagliflozin | 39 | $23K |
| Rivaroxaban | 37 | $17K |
| Sitagliptin Phosphate | 39 | $16K |
| Mirabegron | 41 | $15K |
| Insulin Lispro | 69 | $11K |
| Dapagliflozin Propanediol | 20 | $10K |
| Umeclidinium Brm/Vilanterol Tr | 20 | $9,687 |
| Fluticasone/Vilanterol | 35 | $9,678 |
| Collagenase Clostridium Hist. | 31 | $9,471 |
| Fluticasone/Umeclidin/Vilanter | 17 | $9,239 |
| Atorvastatin Calcium | 630 | $8,751 |
Prescribing Profile
Patient Profile
80
Avg Age
68%
Female
2.63
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About